Ladiratuzumab

Product Graph
390€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Ladiratuzumab
category
Biosimilars
provider
Abbexa
reference
abx831443
tested applications
ELISA, WB

Description

Ladiratuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting SLC39A6, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryBiosimilars
Immunogen TargetSLC39A6
HostHuman
ReactivityHuman
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
ConjugationUnconjugated
IsotypeIgG1 Kappa
ExpressionRecombinant
Purity> 95%
PurificationPurified from cell culture supernatants by Protein A/G chromatography.
Size 1100 µg
Size 21 mg
FormLiquid
Tested ApplicationsELISA, WB
Buffer0.01 M PBS. pH 7.4.
AvailabilityShipped within 7-12 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
AliasBiosimilars
StatusRUO
NoteConcentration: Batch-dependent, typically between 0.5-2.0 mg/ml. CAS Number: 1629760-28-6 This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products
AA E-1000
Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
AA E-1000R
Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
AA E-1100
DHEA-S ELISA
Enzyme immunoassay for the direct quantitative determination of DHEA-S in human serum.
Ver Producto